|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
271:32197-32203
(1996)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of an antagonist mutant of human growth hormone, G120R, in complex with its receptor at 2.9 A resolution.
|
|
M.Sundström,
T.Lundqvist,
J.Rödin,
L.B.Giebel,
D.Milligan,
G.Norstedt.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human growth hormone binds two receptor molecules and thereby induces signal
transduction through receptor dimerization. At high concentrations, growth
hormone acts as an antagonist because of a large difference in affinities at the
respective binding sites. This antagonist action can be enhanced further by
reducing binding in the low affinity binding site. A growth hormone antagonist
mutant Gly-120 --> Arg, has been crystallized with its receptor as a 1:1 complex
and the crystal structure determined at 2.9 A resolution. The 1:1 complex is
remarkably similar to the native growth hormone-receptor 1:2 complex. A
comparison between the two structures reveals only minimal differences in the
conformations of the hormone or its receptor in the two complexes, including the
angle between the two immunoglobulin-like domains of the receptor. Further, two
symmetry-related 1:1 complexes in the crystal form a 2:2 complex with a large
solvent inaccessible area between two receptor molecules. In addition, we
present here a native human growth hormone-human growth hormone-binding protein
1:2 complex structure at 2.5 A resolution. One important difference between our
structure and the previously published crystal structure at 2.8 A is revealed.
Trp-104 in the receptor, a key residue in the hormone-receptor interaction, has
an altered conformation in the low affinity site enabling a favorable hydrogen
bond to be formed with Asp-116 of the hormone.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Schematic representation of the general architecture
of the 1:2 complex. The two receptor molecules are in red (high
affinity) and yellow (low affinity). The picture was generated^
using MOLSCRIPT (36) and raster3D (37).
|
 |
Figure 4.
Fig. 4. Planar stacking of hydrophobic and Arg/Lys residues
in domain 2 of the binding protein. The 2F[o]F[c]^ electron
density map of the 1:2 complex is contoured at 1.0.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(1996,
271,
32197-32203)
copyright 1996.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
F.Mulinacci,
S.E.Bell,
M.A.Capelle,
R.Gurny,
and
T.Arvinte
(2011).
Oxidized recombinant human growth hormone that maintains conformational integrity.
|
| |
J Pharm Sci,
100,
110-122.
|
 |
|
|
|
|
 |
D.J.Diller,
C.Humblet,
X.Zhang,
and
L.M.Westerhoff
(2010).
Computational alanine scanning with linear scaling semiempirical quantum mechanical methods.
|
| |
Proteins,
78,
2329-2337.
|
 |
|
|
|
|
 |
D.Poger,
and
A.E.Mark
(2010).
Turning the growth hormone receptor on: evidence that hormone binding induces subunit rotation.
|
| |
Proteins,
78,
1163-1174.
|
 |
|
|
|
|
 |
W.Q.Chen,
A.Salmazo,
M.Myllykoski,
B.Sjöblom,
M.Bidlingmaier,
A.Pollak,
P.Baumgärtel,
K.Djinovic-Carugo,
P.Kursula,
and
G.Lubec
(2010).
Purification of recombinant growth hormone by clear native gels for conformational analyses: preservation of conformation and receptor binding.
|
| |
Amino Acids,
39,
859-869.
|
 |
|
|
|
|
 |
S.Deechongkit,
J.Wen,
L.O.Narhi,
Y.Jiang,
S.S.Park,
J.Kim,
and
B.A.Kerwin
(2009).
Physical and biophysical effects of polysorbate 20 and 80 on darbepoetin alfa.
|
| |
J Pharm Sci,
98,
3200-3217.
|
 |
|
|
|
|
 |
V.Borromeo,
J.Sereikaite,
V.A.Bumelis,
C.Secchi,
A.Scirè,
A.Ausili,
S.D'Auria,
and
F.Tanfani
(2008).
Mink growth hormone structural-functional relationships: effects of renaturing and storage conditions.
|
| |
Protein J,
27,
170-180.
|
 |
|
|
|
|
 |
J.F.Langenheim,
D.Tan,
A.M.Walker,
and
W.Y.Chen
(2006).
Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
|
| |
Mol Endocrinol,
20,
661-674.
|
 |
|
|
|
|
 |
C.Dos Santos,
L.Essioux,
C.Teinturier,
M.Tauber,
V.Goffin,
and
P.Bougnères
(2004).
A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone.
|
| |
Nat Genet,
36,
720-724.
|
 |
|
|
|
|
 |
S.T.Walsh,
L.M.Jevitts,
J.E.Sylvester,
and
A.A.Kossiakoff
(2003).
Site2 binding energetics of the regulatory step of growth hormone-induced receptor homodimerization.
|
| |
Protein Sci,
12,
1960-1970.
|
 |
|
|
|
|
 |
Y.Kurihara,
T.Watanabe,
H.Nojima,
M.Takeda-Shitaka,
H.Sumikawa,
K.Kamiya,
and
H.Umeyama
(2003).
Dynamic character of human growth hormone and its receptor: normal mode analysis.
|
| |
Chem Pharm Bull (Tokyo),
51,
754-758.
|
 |
|
|
|
|
 |
A.V.Filikov,
R.J.Hayes,
P.Luo,
D.M.Stark,
C.Chan,
A.Kundu,
and
B.I.Dahiyat
(2002).
Computational stabilization of human growth hormone.
|
| |
Protein Sci,
11,
1452-1461.
|
 |
|
|
|
|
 |
D.K.Smith,
and
H.R.Treutlein
(1998).
LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.
|
| |
Protein Sci,
7,
886-896.
|
 |
|
|
|
|
 |
H.W.Christinger,
P.A.Elkins,
Y.Sandowski,
E.Sakal,
A.Gertler,
A.A.Kossiakoff,
and
A.M.de Vos
(1998).
Crystallization of ovine placental lactogen in a 1:2 complex with the extracellular domain of the rat prolactin receptor.
|
| |
Acta Crystallogr D Biol Crystallogr,
54,
1408-1411.
|
 |
|
|
|
|
 |
R.J.Simpson,
A.Hammacher,
D.K.Smith,
J.M.Matthews,
and
L.D.Ward
(1997).
Interleukin-6: structure-function relationships.
|
| |
Protein Sci,
6,
929-955.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |